Advanced search
Publication Cover
Leukemia & Lymphoma Volume 60, 2019 - Issue 5
Submit an article Journal homepage
143
Views
4
CrossRef citations to date
0
Altmetric
Letter to the Editor

Co-expression of AML1-ETO and PML-RARa following treatment of de novo acute myeloid leukemia with AML1-ETO

Shuling ZhangThe First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China;
,
Wei ZhouRespiratory medicine department, Beijing Geriatric Hospital, Beijing, China;
,
Yanchun LiDepartment of Hematology, Shanxi Provincial People’s Hospital, Xian, Shanxi, China;
,
Shuili YuPeople’s Hospital of Jingyuan County, Jingyuan, Baiyin, Gansu, China;
,
Mingming XueThe First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China;
,
Yanhong QiaoThe First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China;
,
Jinli JianThe First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China;
,
Bei LiuThe First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China; ;Department of Hematology, The First Affiliated Hospital, Lanzhou University, Lanzhou, Gansu, China; Correspondence[email protected] [email protected]
&
Degui WangDepartment of Anatomy and Histology, Lanzhou University, School of Basic Medical Sciences, Lanzhou, China
 show all
Pages 1316-1319 | Received 26 Jun 2018, Accepted 01 Sep 2018, Published online: 17 Oct 2018

References

  • Charrin C, Ritouet D, Campos L, et al. Association of t(15;17) and t(8;21) in the initial phase of an acute promyelocytic leukemia. Cancer Genet Cytogenet. 1992;58:177–180.
  • Abreu e Lima RS, Baruffi MR, de Lima AS, et al. The co-expression of PML/RAR alpha and AML1/ETO fusion genes is associated with ATRA resistance. Br J Haematol. 2005;128:407–409.
  • Uz B, Eliaçık E, Işık A, et al. Co-expression of t(15;17) and t(8;21) in a case of acute promyelocytic leukemia: review of the literature. Turk J Haematol. 2013;30:400–404.
  • He G, Wang C, Li Q, et al. Clinical and laboratory features of seven patients with acute myeloid leukemia (AML)-M2/M3 and elevated myeloblasts and abnormal promyelocytes. Cancer Cell Int. 2014;14:111.
  • Stavroyianni N, Kalmantis T, Yataganas X. Simultaneous PML/RAR alpha and AML 1/ETO gene rearrangements in a patient with acute myeloid leukemia. Leukemia. 1999;13:1294–1295.
  • Grimwade D, Hills RK, Moorman AV, et al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood. 2010;116:354–365.
  • Martens JH, Mandoli A, Simmer F, et al. ERG and FLI1 binding sites demarcate targets for aberrant epigenetic regulation by AML1-ETO in acute myeloid leukemia. Blood. 2012;120:4038–4048.
  • Saeed S, Logie C, Francoijs KJ, et al. Chromatin accessibility, p300, and histone acetylation define PML-RARα and AML1-ETO binding sites in acute myeloid leukemia. Blood. 2012;120:3058–3068.
  • Singh AA, Mandoli A, Prange KH, et al. AML associated oncofusion proteins PML-RARA, AML1-ETO and CBFB-MYH11 target RUNX/ETS-factor binding sites to modulate H3ac levels and drive leukemogenesis. Oncotarget. 2017;8:12855–12865.
  • Rashidi A, Fisher SI. Therapy-related acute promyelocytic leukemia: a systematic review. Med Oncol. 2013;30:625.
  • Mistry AR, Felix CA, Whitmarsh RJ, et al. DNA topoisomerase II in therapy-related acute promyelocytic leukemia. N Engl J Med. 2005;352:1529–1538.
  • Ravandi F. Therapy-related acute promyelocytic leukemia. Haematologica. 2011;96:493–495.
  • Infante-Rivard C, Amre DK. Congenital anomalies in children with acute lymphoblastic leukaemia and in their family. Int J Epidemiol. 2001;30:350–352.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.